作者: Millie D. Long , Ajay Gulati , David Wohl , Hans Herfarth
DOI: 10.1097/MIB.0000000000000395
关键词:
摘要: As the treatment of inflammatory bowel disease (IBD) becomes more complex and increasingly relies on combinations immunosuppression in patients with moderate to severe ulcerative colitis or Crohn's disease, provider must be aware recommendations for appropriate use vaccines-both inactivated live. The timing type vaccination required may altered based underlying medical IBD. In some instances, titers assess vaccine response. Vaccination have changed dramatically over past 5 years direct implications protection There are several newly licensed vaccines new by U.S. Advisory Committee Immunization Practices Infectious Diseases Society America defining degrees certain live these levels. This review provides a case-based approach vaccinating pediatric adult IBD, an emphasis practicality. Case scenarios include children adults diagnosed chronic Recommendations management provided, including special circumstances such as pregnancy infant vaccinations when mother is receiving immunosuppressive medication.